381 related articles for article (PubMed ID: 20215553)
41. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
42. The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.
Widschwendter P; Friedl TW; Schwentner L; DeGregorio N; Jaeger B; Schramm A; Bekes I; Deniz M; Lato K; Weissenbacher T; Kost B; Andergassen U; Jueckstock J; Neugebauer J; Trapp E; Fasching PA; Beckmann MW; Schneeweiss A; Schrader I; Rack B; Janni W; Scholz C
Breast Cancer Res; 2015 Sep; 17(1):129. PubMed ID: 26385214
[TBL] [Abstract][Full Text] [Related]
43. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT
J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512
[TBL] [Abstract][Full Text] [Related]
44. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
45. Impact of body mass index and its change on survival outcomes in patients with early breast cancer: A pooled analysis of individual-level data from BCIRG-001 and BCIRG-005 trials.
Chen H; Qian X; Tao Y; Wang D; Wang Y; Yu Y; Yao H
Breast; 2023 Oct; 71():1-12. PubMed ID: 37429049
[TBL] [Abstract][Full Text] [Related]
46. Extremes in body mass index affect overall survival in women with cervical cancer.
Clark LH; Jackson AL; Soo AE; Orrey DC; Gehrig PA; Kim KH
Gynecol Oncol; 2016 Jun; 141(3):497-500. PubMed ID: 27058838
[TBL] [Abstract][Full Text] [Related]
47. Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma.
Hendifar A; Osipov A; Khanuja J; Nissen N; Naziri J; Yang W; Li Q; Tuli R
PLoS One; 2016; 11(3):e0152172. PubMed ID: 27015568
[TBL] [Abstract][Full Text] [Related]
48. Impact of Weight Changes After the Diagnosis of Stage III Colon Cancer on Survival Outcomes.
Vergidis J; Gresham G; Lim HJ; Renouf DJ; Kennecke HF; Ruan JY; Chang JT; Cheung WY
Clin Colorectal Cancer; 2016 Mar; 15(1):16-23. PubMed ID: 26281943
[TBL] [Abstract][Full Text] [Related]
49. Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status.
Rego RL; Foster NR; Smyrk TC; Le M; O'Connell MJ; Sargent DJ; Windschitl H; Sinicrope FA
Br J Cancer; 2010 Jan; 102(1):165-72. PubMed ID: 19997103
[TBL] [Abstract][Full Text] [Related]
50. Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery.
Nakagawa T; Toyazaki T; Chiba N; Ueda Y; Gotoh M
Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):560-6. PubMed ID: 27252238
[TBL] [Abstract][Full Text] [Related]
51. Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
Chung IY; Lee JW; Lee JS; Park YR; Min YH; Lee Y; Yoon TI; Sohn G; Lee SB; Kim J; Kim HJ; Ko BS; Son BH; Ahn SH
PLoS One; 2017; 12(3):e0170311. PubMed ID: 28248981
[TBL] [Abstract][Full Text] [Related]
52. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Meyerhardt JA; Sato K; Niedzwiecki D; Ye C; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Wigler DS; Venook A; Fuchs CS
J Natl Cancer Inst; 2012 Nov; 104(22):1702-11. PubMed ID: 23136358
[TBL] [Abstract][Full Text] [Related]
53. The prognostic effect of adjuvant chemotherapy in the colon cancer patients with solitary lymph node metastasis.
Yeom SS; Lee SY; Kim CH; Kim HR; Kim YJ
Int J Colorectal Dis; 2019 Aug; 34(8):1483-1490. PubMed ID: 31292725
[TBL] [Abstract][Full Text] [Related]
54. Body Mass Index and Survival in a Prospective Randomized Trial of Localized High-Risk Renal Cell Carcinoma.
Donin NM; Pantuck A; Klöpfer P; Bevan P; Fall B; Said J; Belldegrun AS; Chamie K
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1326-32. PubMed ID: 27418270
[TBL] [Abstract][Full Text] [Related]
55. Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients.
Kanemasa Y; Shimoyama T; Sasaki Y; Tamura M; Sawada T; Omuro Y; Hishima T; Maeda Y
Hematol Oncol; 2018 Feb; 36(1):76-83. PubMed ID: 28449294
[TBL] [Abstract][Full Text] [Related]
56. A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia.
Crysandt M; Kramer M; Ehninger G; Bornhäuser M; Berdel WE; Serve H; Röllig C; Kaifie A; Jost E; Brummendorf TH; Wilop S
Eur J Haematol; 2016 Jul; 97(1):17-24. PubMed ID: 26277604
[TBL] [Abstract][Full Text] [Related]
57. Overweight, obesity, and breast cancer screening: results from the 2012 Swiss Health Survey.
Eichholzer M; Richard A; Rohrmann S; Schmid S; Güth U
Eur J Cancer Prev; 2016 Mar; 25(2):130-6. PubMed ID: 25793921
[TBL] [Abstract][Full Text] [Related]
58. Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.
McCollum AD; Catalano PJ; Haller DG; Mayer RJ; Macdonald JS; Benson AB; Fuchs CS
J Natl Cancer Inst; 2002 Aug; 94(15):1160-7. PubMed ID: 12165641
[TBL] [Abstract][Full Text] [Related]
59. A paradox between preoperative overweight/obesity and change in weight during postoperative chemotherapy and its relationship to survival in stage Ⅱ and Ⅲ colorectal cancer patients.
Hu C; Zhang Q; Jin X; Zhang L; Zhang Y; Zhu Q; Tang M; Lyv G; Shi H
Clin Nutr; 2021 Apr; 40(4):2410-2419. PubMed ID: 33183882
[TBL] [Abstract][Full Text] [Related]
60. Being Overweight or Obese Increases the Risk of Progression in Triple-Negative Breast Cancer after Surgical Resection.
Choi Y; Park SK; Ahn KJ; Cho H; Kim TH; Yoon HK; Lee YH
J Korean Med Sci; 2016 Jun; 31(6):886-91. PubMed ID: 27247497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
